JP2022548869A5 - - Google Patents

Info

Publication number
JP2022548869A5
JP2022548869A5 JP2022516358A JP2022516358A JP2022548869A5 JP 2022548869 A5 JP2022548869 A5 JP 2022548869A5 JP 2022516358 A JP2022516358 A JP 2022516358A JP 2022516358 A JP2022516358 A JP 2022516358A JP 2022548869 A5 JP2022548869 A5 JP 2022548869A5
Authority
JP
Japan
Prior art keywords
hexahydro
carbamoyl
cyano
sulfonimidoamide
indacen
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2022516358A
Other languages
English (en)
Japanese (ja)
Other versions
JP2022548869A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/IB2020/058464 external-priority patent/WO2021048809A1/en
Publication of JP2022548869A publication Critical patent/JP2022548869A/ja
Publication of JP2022548869A5 publication Critical patent/JP2022548869A5/ja
Pending legal-status Critical Current

Links

JP2022516358A 2019-09-12 2020-09-11 新規な置換スルホキシミン誘導体 Pending JP2022548869A (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
IN201921036803 2019-09-12
IN201921036803 2019-09-12
PCT/IB2020/058464 WO2021048809A1 (en) 2019-09-12 2020-09-11 Novel substituted sulfoximine derivatives

Publications (2)

Publication Number Publication Date
JP2022548869A JP2022548869A (ja) 2022-11-22
JP2022548869A5 true JP2022548869A5 (https=) 2023-08-01

Family

ID=74866664

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2022516358A Pending JP2022548869A (ja) 2019-09-12 2020-09-11 新規な置換スルホキシミン誘導体

Country Status (5)

Country Link
US (1) US12377070B2 (https=)
EP (1) EP4027986A4 (https=)
JP (1) JP2022548869A (https=)
CN (1) CN114746087A (https=)
WO (1) WO2021048809A1 (https=)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2024180521A1 (en) * 2023-03-02 2024-09-06 Zydus Lifesciences Limited Treatment for inflammatory bowel disease
WO2025153532A1 (en) 2024-01-16 2025-07-24 NodThera Limited Nlrp3 inhibitors and glp-1 agonists combination therapies

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4666506A (en) * 1984-08-08 1987-05-19 E. I. Du Pont De Nemours And Company Herbicidal pyrimidines
US5258406A (en) * 1991-12-20 1993-11-02 Eli Lilly And Company Sulfonimidamides
AU723895B2 (en) * 1997-01-29 2000-09-07 Pfizer Inc. Sulfonyl urea derivatives and their use in the control of interleukin-1 activity
US6906063B2 (en) 2000-02-04 2005-06-14 Portola Pharmaceuticals, Inc. Platelet ADP receptor inhibitors
KR102727059B1 (ko) * 2015-02-16 2024-11-05 더 유니버서티 어브 퀸슬랜드 설포닐우레아와 관련 화합물 및 그 용도
EP3634951B8 (en) 2017-06-09 2024-08-21 Zydus Lifesciences Limited Novel substituted sulfoximine compounds
US11518739B2 (en) * 2017-08-15 2022-12-06 Inflazome Limited Sulfonamide carboxamide compounds
WO2019043610A1 (en) * 2017-08-31 2019-03-07 Cadila Healthcare Limited NEW SUBSTITUTED SULFONYLUREA DERIVATIVES
US11623922B2 (en) * 2017-10-03 2023-04-11 Inflazome Limited Compounds
CN120208846A (zh) * 2019-01-14 2025-06-27 载度思生命科学有限公司 经取代的磺酰脲类衍生物
EP4110058A4 (en) * 2020-02-28 2024-03-20 Zydus Lifesciences Limited Novel substituted sulfonylurea and sulfoximineurea derivatives

Similar Documents

Publication Publication Date Title
RU2312860C2 (ru) Циклические ингибиторы протеинтирозинкиназ
RU2454411C2 (ru) Производные хинолина
RU2454405C2 (ru) Производные 3-пиридинкарбоксамида и 2-пиразинкарбоксамида в качестве агентов, повышающих уровень лвп-холестерина
JP2013516395A5 (https=)
RU2001130452A (ru) Циклические ингибиторы протеинтирозинкиназ
JP2014511869A5 (https=)
JP2021515033A5 (https=)
RU2013108641A (ru) Способ лечения офтальмологических заболеваний с использованием соединений ингибиторов киназы в пролекарственных формах
HRP20220297T1 (hr) Aminoimidazopiridazini kao inhibitori kinaze
US20040209930A1 (en) Synergistic methods and compositions for treating cancer
RU2221796C2 (ru) Производные аминов
RU2005121667A (ru) 5-замещенные пиразиновые или пиридиновые активаторы глюкокиназы
JP2007519754A5 (https=)
RU2005109561A (ru) Новые производные аминоиндазолов в качестве лекарственных средств и содержащие их фармацевтические композиции
RU2008112683A (ru) Ингибиторы fap
IL264982B (en) Hetero(aryl)cyclopropylamine compounds as lsd1 inhibitors
CA2565813A1 (en) Substituted methyl aryl or heteroaryl amide compounds
RU2004117545A (ru) Аминопиримидины и пиридины
JP2019507179A5 (https=)
RU2003136772A (ru) Содержащие неароматическое гетероциклическое кольцо диамидные агенты для борьбы с беспозвоночными вредителями
JP2011504497A5 (https=)
RU2013143028A (ru) Тиазолилфенилбензолсульфонамидопроизводные в качестве ингибиторов киназ
HRP20120656T1 (hr) Derivati indazolil amida za liječenje poremećaja posredovanih glukokortikoidnim receptorom
JP2011526616A5 (https=)
RU2000114635A (ru) Бензотиазольные ингибиторы протеинтирозинкиназ